Multispecific yet truly natural antibodies

Multispecific yet truly natural antibodies

Multispecific yet truly natural antibodies

Light Chain Bioscience brings to life the research and development of multi-specific antibodies that rely on their light chains for function
Who we are
Who we are

Our antibody development roots go deep

Our antibody development roots go deep

Read more
Our focus
Our focus

Multispecific yet natural

Multispecific yet natural

Read more
CD47 Dual targeting
CD47 Dual targeting

Safe and selective blockade of CD47 on tumors

Safe and selective blockade of CD47 on tumors

Read more
Looking into the future
Looking into the future

Beyond bispecific antibodies

Beyond bispecific antibodies

Read more
previous arrow
next arrow
TM & © Novimmune SA. All rights reserved.
webdesign byhosted climate friendly

First patient dosed with NILK-2301 in Phase I clinical trial

Written by Mei Liang Belhumeur on . Posted in News

First-in-human trial of a CEACAM5xCD3 bispecific κλ body for solid cancer

Read more

LinkedIn